This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Japan Science and Technology Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Tetsu Yoshida: Innovator in Protein Expression Inhibition
Introduction
Tetsu Yoshida is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of protein expression inhibitors. His work has the potential to impact therapeutic approaches for various central nervous system diseases.
Latest Patents
Tetsu Yoshida holds a patent for "Numb protein expression inhibitors by Musashi." This invention involves an Numb protein expression inhibitor that comprises Musashi protein as the active ingredient. The polypeptide has an amino acid sequence modified through replacement, deletion, addition, or insertion of at least one amino acid from the original Musashi protein sequence. This innovation elucidates a new function of Musashi protein, which inhibits the expression of Numb protein, a key regulator of neuronal differentiation. Furthermore, it enhances the activity of the Notch signaling system, making Musashi protein a promising therapeutic candidate for various central nervous system diseases.
Career Highlights
Tetsu Yoshida is affiliated with the Japan Science and Technology Corporation, where he continues to advance his research and development efforts. His work is characterized by a commitment to understanding the molecular mechanisms underlying neuronal functions and their implications for health.
Collaborations
Tetsu has collaborated with notable colleagues, including Akinori Tokunaga and Hideyuki Okano. These partnerships have fostered a collaborative environment that enhances the innovation process and contributes to the advancement of their shared research goals.
Conclusion
Tetsu Yoshida's contributions to the field of protein expression inhibition highlight his role as an influential inventor. His innovative work has the potential to lead to significant advancements in therapeutic strategies for central nervous system diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
